Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Induced pluripotent stem cells derived from patients carrying mitochondrial mutations exhibit altered bioenergetics and aberrant differentiation potential

Fig. 3

Mitochondrial disease patient hiPSCs express cell surface pluripotency markers. SSEA4, TRA-1-60 and TRA-1-81. Healthy control BJ-hiPSC (a, f, k) and diseased SBG1-hiPSC (b, g, l), SBG2-hiPSC (c, h, m), SBG3-hiPSC (d, i, n) and SBG5-hiPSC e, j, o are positive for SSEA4 (a–e), TRA1-60 f–j and TRA-1–81 (k–o) cell surface markers. Image inserts contain corresponding DAPI nuclear counterstain. DAPI, 4’,6-diamidino-2-phenylindole. Scale bar = 100 µm

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512